ABOVE: © ISTOCK.COM, JETCITYIMAGE
The European Medicines Agency has concluded that certain unusual types of blood clots are a very rare side effect of the Oxford/AstraZeneca COVID-19 vaccine, according to a statement the agency posted yesterday (April 7). These clots, which are associated with low blood platelet counts, have been reported in connection with a handful of deaths among the more than 34 million people who have received the vaccine in Europe and the UK, prompting several countries to alter their immunization rollouts in recent weeks.
Sabine Straus, chair of the committee that produced the EMA report, said at a press conference yesterday that the rate of cases appeared to be about 1 in 100,000 vaccinated people. According to the statement, the agency based its analysis on nearly 90 cases of blood clots, 18 of which were fatal. “The reported combination of blood clots and low blood platelets is very ...
